FORE Biotherapeutics, announced the appointment of William R. Hinshaw as the Chief Executive Officer and Director of the Board.
Mr. Hinshaw is a 30+-year veteran...
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is pleased to announce a strategic supply agreement with ALZpath, a...
Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications,...
Ionis Pharmaceuticals, Inc., announced, that Kyle Jenne has rejoined Ionis as executive vice president, chief global product strategy officer, to lead all aspects of...
Rigel Pharmaceuticals, Inc., announced that it has entered into a definitive agreement to acquire the U.S. rights to GAVRETO from Blueprint Medicines Corporation. GAVRETO...
